Pharmaceutical - Aspirin

Filter

Current filters:

Aspirin

Popular Filters

Pozen re-files for US approval of PA8140/PA32540

Pozen re-files for US approval of PA8140/PA32540

02-07-2014

US drug firm Pozen has resubmitted the New Drug Application for PA8140/PA32540 (aspirin and omeprazole)…

AspirinCardio-vascularOmeprazolePA8140/PA32540PharmaceuticalPozenRegulationUSA

Third party ingredient supplier issues delay FDA approval for Pozen NDA

27-04-2014

US drugmaker Pozen says that its drug candidates PA8140/PA32540 (aspirin and omeprazole) delayed release…

AspirinCardio-vascularEsomeprazole SodiumNorth AmericaPharmaceuticalPozenRegulationUSA

Sanofi US in deal to commercialize PA8140/PA32540

04-09-2013

The US subsidiary of French drug major Sanofi (Euronext: SAN) has entered into a deal with US drugmaker…

AspirinCardio-vascularGastro-intestinalsLicensingNorth AmericaOmeprazolePharmaceuticalPozenSanofi

Daiichi Sankyo updates on PRASFIT-Elective study, NDA filing

14-03-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) says that the follow-up period for the Phase III PRASFIT-Elective…

Asia-PacificAspirinCardio-vascularDaiichi SankyoEffientPharmaceuticalprasugrelRegulationResearch

Aspirin may lower risk of melanoma, researchers suggest

11-03-2013

A new study has found that women who take aspirin have a reduced risk of developing melanoma - and that…

AspirinOncologyPharmaceuticalResearchWomen's Health

Latest role for aspirin may be in protecting against Barrett's esophagus

24-07-2012

Along with its original use as a pain killer, and its protection against heart attack, the ubiquitous…

AspirinGastro-intestinalsPharmaceuticalResearch

Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug

18-07-2012

Ticagrelor, Anglo-Swedish drug major AstraZeneca's (LSE: AZN) blood-thinning drug Brilique/Brilinta which…

AspirinAstraZenecaBrilintaBriliqueCardio-vascularClopidogrelNorth AmericaPharmaceuticalprasugrelRegulation

Pozen rockets on positive Ph III trial results with aspirin combo drug

23-03-2012

USA-based Pozen (Nasdaq: POZN) saw its shares leap 9% to $5.24 on Thursday morning, having risen nearly…

AspirinCardio-vascularGastro-intestinalsOmeprazolePharmaceuticalPozenResearch

Clopidogrel with aspirin does not prevent more small strokes

05-02-2012

The anti-blood clot regimen that adds the drug clopidogrel (French drug major Sanofi’s blockbuster…

AspirinCardio-vascularClopidogrelPharmaceuticalPlavixResearchSanofi

Back to top